• Biologically active substances associated with cancer studied using MS
    Invasive breast cancer is driven by specific biologically active substances, research suggests


Biologically active substances associated with cancer studied using MS

Jul 13 2010

Mass spectrometry (MS) has been used to examine the biologically active substances associated with breast cancer.

Ghent University, Belgium's oldest and largest public university, undertook the research in collaboration with Imperial College London and the US National Human Genome Research Institute.

MS was used to identify a chaperone molecule, HSP90-alpha, as one of the biologically active substances that promotes invasive growth in breast cancers.

The finding was part of scientists' efforts to prove that Rab27B, part of a family of guanosine triphosphate binding enzymes, promotes invasiveness of breast cancer tumours.

According to their discoveries, increased expression of Rab27B "is associated with poor prognosis in humans".

However, derailing the exocytosis - the release of vesicle content - associated with Rab27B can help to regulate invasive tumour growth and metastasis in some breast cancers.

The scientists conclude that "considerable therapeutic potential" lies in the future development of Rab27B as an avenue for cancer treatments.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

AOCS Annual Meeting & Expo

Apr 28 2024 Montreal, Quebec, Canada

SETAC Europe

May 05 2024 Seville, Spain

ChemUK 2024

May 15 2024 Birmingham, UK

View all events